Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -87.79% is 51% above its 5-year average of -178.20%, near the high end of its 5-year range (-3384.98%–-43.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 51.10% above its 12-month average of -179.53%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -87.79%.
RETURN ON INVESTED CAPITAL (ROIC)
-87.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-179.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-318.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-178.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-191.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-191.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-141.32%
CURRENT VS TTM AVG
+51.10%
CURRENT VS 3Y AVG
+72.43%
CURRENT VS 5Y AVG
+50.74%
CURRENT VS 10Y AVG
+54.20%
CURRENT VS 15Y AVG
+54.23%
CURRENT VS 20Y AVG
+37.88%
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-146.28%
vs the sector median at left
ProMIS Neurosciences, Inc.
Market Cap
$81.79M
Return on Invested Capital (ROIC)
-87.79%
TTM Avg
-179.53%
3Y Avg
-318.37%
5Y Avg
-178.20%
Market Cap
$81.38M
Return on Invested Capital (ROIC)
-126.99%
TTM Avg
-110.63%
3Y Avg
-85.52%
5Y Avg
-67.36%
Market Cap
$82.08M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
Market Cap
$82.47M
Return on Invested Capital (ROIC)
-16.28%
TTM Avg
-50.22%
3Y Avg
-41.74%
5Y Avg
-37.86%
Market Cap
$79.83M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$83.18M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-27.86%
3Y Avg
-23.01%
5Y Avg
-20.58%
Market Cap
$83.82M
Return on Invested Capital (ROIC)
-120.93%
TTM Avg
-913.64%
3Y Avg
-646.22%
5Y Avg
-579.89%
Market Cap
$79.83M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$84.13M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProMIS Neurosciences, Inc. (PMN) | $81.79M | -87.79% | -179.53% | -318.37% | -178.20% |
| Nutriband Inc. (NTRB)vs › | $81.38M | -126.99% | -110.63% | -85.52% | -67.36% |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.08M | -159.30% | -82.85% | -66.58% | -50.22% |
| LENSAR Inc (LNSR)vs › | $82.47M | -16.28% | -50.22% | -41.74% | -37.86% |
| Humacyte, Inc. (HUMA)vs › | $79.83M | -90.27% | -103.33% | -85.38% | -72.83% |
| MediciNova, Inc. (MNOV)vs › | $83.18M | -31.62% | -27.86% | -23.01% | -20.58% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $83.82M | -120.93% | -913.64% | -646.22% | -579.89% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.83M | -88.28% | -61.59% | -48.92% | -67.61% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | -109.43% | -208.02% | -178.83% | -203.50% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.44M | -11.48% | -56.27% | -1130.61% | -797.97% |
ROIC
-87.8%
ROE
-85.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -87.79% |
| 2026-03-31 | -68.02% |
| 2025-09-30 | -382.80% |
| 2025-03-31 | -214.91% |
| 2024-12-31 | -100.81% |
| 2024-09-30 | -67.20% |
| 2024-03-31 | -1436.97% |
| 2023-12-31 | -334.03% |
| 2023-09-30 | -172.80% |
| 2022-12-31 | -3384.98% |
| 2022-09-30 | -603.05% |
| 2022-06-30 | -135.23% |
| 2022-03-31 | -65.64% |
| 2021-12-31 | -43.60% |
| 2021-09-30 | -54.52% |
| 2021-06-30 | -164.42% |
| 2021-03-31 | -114.69% |
| 2019-12-31 | -2741.92% |
| 2019-06-30 | -536.51% |
| 2019-03-31 | -149.66% |
| 2018-12-31 | 74.29% |
| 2018-09-30 | -142.53% |
| 2018-06-30 | -86.93% |
| 2018-03-31 | -324.60% |
| 2017-12-31 | -365.99% |
| 2017-09-30 | -193.58% |
| 2017-03-31 | -135.01% |
| 2016-12-31 | -423.06% |
| 2016-09-30 | -92.48% |
| 2016-06-30 | -189.85% |
| 2016-03-31 | -189.31% |
| 2015-12-31 | -278.34% |
| 2015-09-30 | -82.31% |
| 2014-03-31 | -8242.55% |
| 2013-06-30 | -7817.53% |
| 2012-12-31 | -1083.31% |
| 2012-09-30 | -285.24% |
| 2012-06-30 | -154.45% |
| 2012-03-31 | -139.74% |
| 2011-12-31 | -258.71% |
| 2011-09-30 | -231.07% |
| 2011-06-30 | -109.73% |
| 2011-03-31 | -164.69% |
| 2010-12-31 | -174.27% |
| 2010-09-30 | -152.16% |
| 2010-06-30 | -210.95% |
| 2010-03-31 | -94.22% |
| 2009-12-31 | -73.67% |
| 2009-09-30 | -62.50% |
| 2009-06-30 | -64.09% |
| 2009-03-31 | -130.40% |
| 2008-12-31 | -123.74% |
| 2008-09-30 | -101.96% |
| 2008-06-30 | -96.26% |
| 2008-03-31 | -82.60% |
| 2007-12-31 | -62.79% |
| 2007-09-30 | -48.45% |
| 2007-06-30 | -37.10% |
| 2007-03-31 | -30.88% |
| 2006-12-31 | -59.77% |
| 2006-09-30 | -50.41% |
| 2006-06-30 | -45.41% |
| 2006-03-31 | -36.88% |
